Illumina Announces HumanHap550+ and iSelect Infinium(TM) Genotyping Products
Thursday July 13, 6:00 am ET
Flexible Offering Enables Design of Custom Array Content to Analyze up to 670,000 SNPs or 12 Samples on a Single BeadChip
SAN DIEGO--(BUSINESS WIRE)--July 13, 2006--Illumina, Inc. (NASDAQ:ILMN - News) announced today the immediate availability of two new Infinium genotyping products that provide an unprecedented degree of customization for customers performing whole-genome and focused-content SNP (single nucleotide polymorphism) genotyping.
ADVERTISEMENT
The new HumanHap550+ product allows customers to add up to 120,000 custom SNP markers to supplement the standard content provided on the existing HumanHap550 BeadChip, yielding up to 670,000 markers for association studies. For focused-content applications, the new iSelect Infinium product allows customers to create a custom array of up to 60,000 SNP markers per sample with 12 samples per chip. The multi-sample offering will typically be used by researchers who have already performed whole-genome genotyping and/or have narrowed down SNPs of interest to a large, yet focused set of markers relevant to the particular disease they are studying.
Illumina is offering custom Infinium genotyping solutions as either a product or a service. The Company also provides a powerful bioinformatics tool that enables in silico SNP design and screening prior to probe synthesis.
"These new products highlight the flexibility of the BeadChip format," stated Jay Flatley, Illumina President and CEO. "The multi-stripe configuration and versatile gasketing technology developed as part of the BeadChip program allow for rapid production of customer-tailored products, enabling researchers to add custom content to our industry leading HumanHap550 or create fully custom multi-sample chips."
Illumina also announced today a custom Infinium services agreement with Johnson & Johnson Pharmaceutical Development, L.L.C. -- the first such agreement for custom, multi-sample Infinium genotyping.
For more information about custom Infinium genotyping or about other high-performance microarray solutions for genotyping and gene expression studies, contact Illumina's Customer Solutions Department at +1 858 202.4566 or e-mail info@illumina.com.
About Illumina
Illumina (www.illumina.com) develops and markets next-generation tools for the large-scale analysis of genetic variation and function. The Company's proprietary BeadArray technology -- used in leading genomics centers around the world -- provides the throughput, cost effectiveness and flexibility necessary to enable researchers in the life sciences and pharmaceutical industries to perform the billions of tests necessary to extract medically valuable information from advances in genomics and proteomics. This information will help pave the way to personalized medicine by correlating genetic variation and gene function with particular disease states, enhancing drug discovery, allowing diseases to be detected earlier and more specifically, and permitting better choices of drugs for individual patients |
